Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $25.5400 (-4.27%) ($25.5200 - $26.5300) on Sat. Jan. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 57 | Latest Price | $25.5400(-4.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.4% a day on average for past five trading days. | Weekly Trend | IOVA declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -1.735% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | 0 () | Intraday Trend | -2.7% | | | |
|
Resistance Level | $27.11 | 5 Day Moving Average | $27.06(-5.62%) | 10 Day Moving Average | $27.93(-8.56%) | 20 Day Moving Average | $27.11(-5.79%) | To recent high | -13.2% | To recent low | 42.3% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |